Open AccessExpression of programmed death ligand-1 and programmed death 1 in hepatocellular carcinoma and its clinical significance
Author(s) -
Jessica B. Long,
Tao Qu,
X F Pan,
Xuan Tang,
HH Wan,
Pengfei Qiu,
Yan Xu
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.204850
Subject(s) - hepatocellular carcinoma , immunohistochemistry , medicine , stromal cell , pd l1 , stage (stratigraphy) , pathology , cancer research , clinical significance , pathogenesis , biomarker , oncology , cancer , biology , immunotherapy , paleontology , biochemistry
To investigate the correlation between the expression of programmed death 1 (PD-1) and PD ligand-1 (PD-L1) in hepatocellular carcinoma (HCC) and clinical parameters.